| Primary |
| Blood Triglycerides Increased |
16.8% |
| Blood Cholesterol Increased |
13.3% |
| Hypertension |
11.2% |
| Hyperlipidaemia |
9.7% |
| Hypertriglyceridaemia |
7.1% |
| Hypercholesterolaemia |
6.1% |
| Dyslipidaemia |
5.1% |
| Diabetes Mellitus |
4.1% |
| Blood Cholesterol Abnormal |
3.6% |
| Type 2 Diabetes Mellitus |
3.1% |
| Blood Triglycerides Abnormal |
2.6% |
| Complex Regional Pain Syndrome |
2.6% |
| Arteriosclerosis |
2.0% |
| Asthma |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Pain |
2.0% |
| Type V Hyperlipidaemia |
2.0% |
| Anxiety |
1.5% |
| Blood Triglycerides |
1.5% |
| Ill-defined Disorder |
1.5% |
|
| Drug Hypersensitivity |
19.7% |
| Rhabdomyolysis |
7.7% |
| Drug Ineffective |
6.0% |
| Hepatitis |
6.0% |
| Myalgia |
6.0% |
| Rash |
6.0% |
| Vomiting |
6.0% |
| Cerebrovascular Accident |
5.1% |
| Death |
5.1% |
| Muscle Spasms |
4.3% |
| Weight Decreased |
4.3% |
| Blood Triglycerides Increased |
3.4% |
| Liver Function Test Abnormal |
3.4% |
| Pain In Extremity |
3.4% |
| Pain |
2.6% |
| Urticaria |
2.6% |
| Visual Impairment |
2.6% |
| Wrong Drug Administered |
2.6% |
| Abdominal Discomfort |
1.7% |
| Blood Glucose Increased |
1.7% |
|
| Secondary |
| Blood Cholesterol Increased |
22.1% |
| Product Used For Unknown Indication |
17.3% |
| Blood Triglycerides Increased |
7.5% |
| Diabetes Mellitus |
6.2% |
| Hypertension |
5.8% |
| Blood Cholesterol |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Hyperlipidaemia |
4.2% |
| Hypercholesterolaemia |
3.8% |
| Depression |
3.3% |
| Sleep Disorder |
2.7% |
| Cardiac Disorder |
2.4% |
| Hypertriglyceridaemia |
2.4% |
| Arthritis |
2.2% |
| Blood Triglycerides |
2.2% |
| Dyslipidaemia |
2.0% |
| Hypothyroidism |
2.0% |
| Pain |
2.0% |
| Acne |
1.8% |
| Diabetes Mellitus Inadequate Control |
1.3% |
|
| Rhabdomyolysis |
19.2% |
| Drug Hypersensitivity |
10.6% |
| Visual Impairment |
9.6% |
| Weight Decreased |
6.7% |
| Transient Ischaemic Attack |
5.8% |
| Wrong Technique In Drug Usage Process |
4.8% |
| Metastases To Lung |
3.8% |
| Myalgia |
3.8% |
| Pancreatitis |
3.8% |
| Sleep Disorder |
3.8% |
| Toothache |
3.8% |
| Urticaria |
3.8% |
| Diabetes Mellitus Inadequate Control |
2.9% |
| Intracranial Aneurysm |
2.9% |
| Malaise |
2.9% |
| Pain In Extremity |
2.9% |
| Rash |
2.9% |
| Asthenia |
1.9% |
| Biliary Dilatation |
1.9% |
| Blood Cholesterol Increased |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
13.4% |
| Hypertension |
8.8% |
| Diabetes Mellitus |
7.8% |
| Depression |
5.7% |
| Blood Cholesterol Increased |
5.4% |
| Pain |
4.1% |
| Type 2 Diabetes Mellitus |
3.3% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Blood Triglycerides Increased |
2.7% |
| Anxiety |
2.6% |
| Bipolar Disorder |
2.5% |
| Hyperlipidaemia |
2.5% |
| Arthritis |
2.0% |
| Osteoporosis |
2.0% |
| Insomnia |
2.0% |
| Atrial Fibrillation |
1.8% |
| Hiv Infection |
1.8% |
| Blood Cholesterol |
1.8% |
| Hypercholesterolaemia |
1.7% |
|
| Myocardial Infarction |
10.0% |
| Weight Decreased |
9.3% |
| Type 2 Diabetes Mellitus |
9.1% |
| Weight Increased |
8.3% |
| Vomiting |
8.2% |
| Pancreatitis |
6.9% |
| Pain |
5.5% |
| Rhabdomyolysis |
4.0% |
| Transient Ischaemic Attack |
3.9% |
| Urticaria |
3.9% |
| Nausea |
3.5% |
| Cardiac Failure Congestive |
3.4% |
| Pruritus |
3.4% |
| Pneumonia |
3.2% |
| Drug Ineffective |
3.0% |
| Fatigue |
3.0% |
| Rash |
3.0% |
| Paraesthesia |
2.9% |
| Vision Blurred |
2.9% |
| Flushing |
2.6% |
|
| Interacting |
| Hypertension |
12.5% |
| Blood Triglycerides Increased |
10.0% |
| Hypertriglyceridaemia |
10.0% |
| Blood Cholesterol Increased |
7.5% |
| Hypothyroidism |
7.5% |
| Lipids Increased |
7.5% |
| Anticoagulant Therapy |
5.0% |
| Cellulitis |
5.0% |
| Diabetes Mellitus |
5.0% |
| Drug Use For Unknown Indication |
5.0% |
| Gout |
5.0% |
| High Density Lipoprotein Decreased |
5.0% |
| Hypercholesterolaemia |
5.0% |
| Low Density Lipoprotein Increased |
5.0% |
| Vitamin Supplementation |
5.0% |
|
| Somnolence |
27.3% |
| Drug Interaction |
18.2% |
| Pain In Extremity |
18.2% |
| Skin Burning Sensation |
18.2% |
| Urticaria |
18.2% |
|
